Tom Clancy’s Splinter Cell is being adapted into a radio drama on BBC Radio 4, which will begin airing next week.
The eight-part series, which will broadcast on Fridays from December 2 at 2.15pm, follows veteran Fourth Echelon agent Sam Fisher on a new mission, “recruiting and training the next generation of Splinter Cell operatives for the National Security Agency’s covert action division”.
The synopsis reads: “When a lethal assassin from Fisher’s past returns from the dead on a mission of murder, he is thrust into a race against time as a sinister threat to global security is revealed.” Sam Fisher is played by Andonis Anthony . The role of his daughter Sarah, who teams up with her dad, is played by actor Daisy Head.Other cast include Rosalie Craig, Sacha Dhawan and Nikesh Patel, as well Will Poulter .
Poulter said in a statement: “I really hope fans of the Splinter Cell game enjoy this, as not only does it have all the action, tension and excitement that the game is famous for, but it also has more elements. “There is a lot of comedy, the drama is expanded and horizons broadened by the characters and what they get up to. It is taking the best of Splinter Cell and building on that to make something really well rounded.”
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Step aside Netflix, Splinter Cell is getting a BBC Radio 4 adaptationLook out Netflix, Amazon, HBO, and Paramount; the BBC wants in on that juicy video game adaptation action and is bringi…
Læs mere »
BBC Radio 4 - Woman's Hour, Andrea Riseborough, Egg Freezing, Women in QatarAndrea Riseborough has taken on a range of acting roles from Margaret Thatcher to Wallis Simpson. She joins Emmabarnett to discuss her latest incarnation as Mrs Wormwood in the film Matilda the Musical.
Læs mere »
Boy, 5, with sickle cell disease struck with flu in 'terrifying' ordeal as 'paediatric winter' hitsSky's health correspondent Ashish Joshi meets David, who was taken to hospital in excruciating pain and diagnosed with flu, leaving his health under serious threat.
Læs mere »
Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma - Genome MedicineBackground Squamous cell carcinoma (SqCC) is a subtype of non-small cell lung cancer for which patient prognosis remains poor. The extracellular matrix (ECM) is critical in regulating cell behavior; however, its importance in tumor aggressiveness remains to be comprehensively characterized. Methods Multi-omics data of SqCC human tumor specimens was combined to characterize ECM features associated with initiation and recurrence. Penalized logistic regression was used to define a matrix risk signature for SqCC tumors and its performance across a panel of tumor types and in SqCC premalignant lesions was evaluated. Consensus clustering was used to define prognostic matreotypes for SqCC tumors. Matreotype-specific tumor biology was defined by integration of bulk RNAseq with scRNAseq data, cell type deconvolution, analysis of ligand-receptor interactions and enriched biological pathways, and through cross comparison of matreotype expression profiles with aging and idiopathic pulmonary fibrosis lung profiles. Results This analysis revealed subtype-specific ECM signatures associated with tumor initiation that were predictive of premalignant progression. We identified an ECM-enriched tumor subtype associated with the poorest prognosis. In silico analysis indicates that matrix remodeling programs differentially activate intracellular signaling in tumor and stromal cells to reinforce matrix remodeling associated with resistance and progression. The matrix subtype with the poorest prognosis resembles ECM remodeling in idiopathic pulmonary fibrosis and may represent a field of cancerization associated with elevated cancer risk. Conclusions Collectively, this analysis defines matrix-driven features of poor prognosis to inform precision medicine prevention and treatment strategies towards improving SqCC patient outcome.
Læs mere »
CAR T cell therapy could reach beyond cancerEngineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus. Penn Medicine CAR T pioneer Carl June, MD, and Daniel Baker, a doctoral student in Cell and Molecular Biology in the Perelman School of Medicine at the University of Pennsylvania, discuss this development in a commentary published today in Cell.
Læs mere »
Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage - Cell Death & DiseaseCell Death & Disease - Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage
Læs mere »